MINNEAPOLIS, Jan. 03, 2022 (GLOBE NEWSWIRE) — Relievant Medsystems, a privately held medical system firm remodeling the therapy of Power Low Again Ache (CLBP), introduced at the moment that new Class I Present Procedural Terminology (CPT) codes for the Intracept Process are in impact as of January 1, 2022.
The brand new Class I codes for the Intracept Process are:
- 64628: Thermal destruction of intraosseous basivertebral nerve, together with all imaging steerage; first two vertebral our bodies lumbar or sacral; and
- 64629: Thermal destruction of intraosseous basivertebral nerve, together with all imaging steerage; every further vertebral physique, lumbar or sacral
These codes observe the designation of a brand new ICD-10 Prognosis Code particularly for vertebrogenic low again ache–M54.51–by the Facilities for Illness Management and Prevention (CDC), which went into impact in 2021.
“The Intracept Process is a major breakthrough within the therapy of CLBP and has already modified the lives of 1000’s of sufferers,” mentioned Tyler Binney, President and Chief Govt Officer of Relievant Medsystems. “Acquiring CPT I codes is a crucial milestone and demanding step in our effort to determine widespread insurance coverage protection and reimbursement, in order that extra sufferers can profit from the life-changing advantages of the Intracept Process.”
The Intracept Process is supported by greater than 20 years of analysis and two Degree 1 randomized managed trials, with proof demonstrating that enhancements in ache and performance are maintained long-term post-procedure.
About Relievant Medsystems
Relievant Medsystems is a privately held medical system firm that’s remodeling the therapy of Power Low Again Ache (CLBP) with the Intracept Process – a novel, clinically confirmed and commercially obtainable therapy designed to enhance the standard of life for the hundreds of thousands of sufferers affected by CLBP from degenerative disc illness with Modic adjustments, a biomarker indicating that their ache is vertebrogenic in origin. Study extra at www.relievant.com.
Contact:
Chris Geyen, Relievant Medsystems
(650) 368-1000 | buyers@relievant.com
Discussion about this post